Span Divergent
524727 BSE
Span Divergent
Healthcare BSE: 524727 Pharmaceuticals
Key Fundamentals
MicrocapPharmaceuticalsHealthcareMarket Cap
₹21.30 Cr
Volatility
Moderate
P/E Ratio
-5.9
EBITDA
₹-1.30 Cr
Return on Equity
-29.99%
Debt to Equity
0.48
Book Value
₹20.46
52W High
₹51.49
52W Low
₹21.76
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Debtor days have improved from 45.0 to 32.6 days.
Weaknesses
2- Company has low interest coverage ratio.
- Promoter holding has decreased over last 3 years: -15.9%
Growth Rate
Revenue Growth
83.17% higher than
3Y
Net Income Growth
123% higher than
3Y
Cash Flow Change
-88.17% higher than
3Y
ROE
-308% lower than
3Y
ROCE
-397% lower than
3Y
EBITDA Margin (Avg.)
-229% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.43 | 3.18 | 3.01 | 3.03 | 3.71 | 2.8 | 1.9 | 0.55 | 1.07 | 7.65 | 3.86 | 4.65 | 1.02 |
| Expenses | 2.86 | 2.97 | 2.6 | 2.82 | 3.45 | 2.56 | 2.12 | 1.49 | 1.73 | 7.65 | 4.94 | 5.51 | 2.06 |
| Operating Profit | 0.57 | 0.21 | 0.41 | 0.21 | 0.26 | 0.24 | -0.22 | -0.94 | -0.66 | 0 | -1.08 | -0.86 | -1.04 |
| OPM % | 16.62% | 6.6% | 13.62% | 6.93% | 7.01% | 8.57% | -11.58% | -170.91% | -61.68% | 0% | -27.98% | -18.49% | -101.96% |
| Other Income | 0.18 | 0.27 | 0.36 | 0.96 | 0.2 | 0.25 | 0.47 | 0.34 | 0.91 | 0.22 | 0.34 | 0.15 | 0.28 |
| Interest | 0.19 | 0.18 | 0.18 | 0.17 | 0.16 | 0.15 | 0.14 | 0.15 | 0.12 | 0.12 | 0.11 | 0.12 | 0.14 |
| Depreciation | 0.49 | 0.47 | 0.34 | 0.33 | 0.28 | 0.28 | 0.28 | 0.24 | 0.27 | 0.27 | 0.28 | 0.3 | 0.24 |
| PBT | 0.07 | -0.17 | 0.25 | 0.67 | 0.02 | 0.06 | -0.17 | -0.99 | -0.14 | -0.17 | -1.13 | -1.13 | -1.14 |
| Tax % | -100% | 76.47% | 72% | -32.84% | 550% | 16.67% | 23.53% | 4.04% | 21.43% | 11.76% | 0.88% | -0.88% | 3.51% |
| Net Profit | 0.13 | -0.3 | 0.06 | 0.88 | -0.09 | 0.05 | -0.21 | -1.03 | -0.17 | -0.18 | -1.13 | -1.12 | -1.19 |
| EPS in Rs | 0.37 | -0.48 | 0.22 | 1.68 | -0.02 | 0.24 | -0.27 | -1.63 | -0.18 | -0.24 | -1.78 | -1.32 | -1.45 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 75.47 | 0 | 2.87 | 14.57 | 24.14 | 9.38 | 7.4 | 13.09 | 12.52 | 12.33 | 8.96 | 17.22 | 17.18 |
| Expenses | 74.28 | 5.23 | 8.37 | 25.16 | 31.34 | 15.16 | 9.64 | 12.67 | 11.42 | 10.94 | 9.61 | 19.8 | 20.16 |
| Operating Profit | 1.19 | -5.23 | -5.5 | -10.59 | -7.2 | -5.78 | -2.24 | 0.42 | 1.1 | 1.39 | -0.65 | -2.58 | -2.98 |
| OPM % | 1.58% | — | -191.64% | -72.68% | -29.83% | -61.62% | -30.27% | 3.21% | 8.79% | 11.27% | -7.25% | -14.98% | -17.35% |
| Other Income | 53.94 | 9.98 | 4.04 | 2.57 | -0.76 | 1.96 | 0.82 | -7.54 | -3.45 | 1.77 | 1.25 | 1.28 | 0.99 |
| Interest | 4.39 | 0.03 | 0.2 | 1.7 | 1.89 | 1.99 | 1.58 | 1.08 | 1 | 0.72 | 0.6 | 0.43 | 0.49 |
| Depreciation | 5.96 | 0.18 | 0.82 | 2.6 | 3.62 | 3.45 | 3.11 | 2.17 | 2.17 | 1.64 | 1.09 | 1.17 | 1.09 |
| PBT | 44.78 | 4.54 | -2.48 | -12.32 | -13.47 | -9.26 | -6.11 | -10.37 | -5.52 | 0.8 | -1.09 | -2.9 | -3.57 |
| Tax % | 12.93% | 27.97% | 5.24% | 1.46% | 4.31% | -7.02% | 0.82% | -2.12% | -1.81% | 2.5% | 17.43% | 1.38% | — |
| Net Profit | 38.99 | 3.28 | -2.61 | -12.5 | -14.05 | -8.61 | -6.16 | -10.15 | -5.42 | 0.79 | -1.28 | -2.95 | -3.62 |
| EPS in Rs | 53.59 | 6.06 | -4.78 | -22.89 | -22.28 | -14.23 | -10.23 | -17.94 | -9.25 | 1.79 | -1.68 | -3.44 | -4.79 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.28 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 7.26 |
| Reserves | 54.41 | 44.71 | 43.11 | 30.61 | 19.87 | 12.12 | 6.56 | -3.24 | -8.3 | -7.35 | -8.27 | 7.6 |
| Borrowings | 0.34 | 0.19 | 13.12 | 23.18 | 22.3 | 19.19 | 17.99 | 13.19 | 11.15 | 9.11 | 8.36 | 7.14 |
| Other Liabilities | 3.8 | 0.44 | 2.97 | 4.02 | 1.64 | 2.56 | 4.27 | 12.27 | 17.02 | 16.64 | 17.28 | 6.54 |
| Total Liabilities | 65.83 | 50.8 | 64.66 | 63.27 | 49.27 | 39.33 | 34.28 | 27.68 | 25.33 | 23.86 | 22.83 | 28.54 |
| Fixed Assets | 2.2 | 2.15 | 8.15 | 25.91 | 22.47 | 20.19 | 17.72 | 15.36 | 13.12 | 10.75 | 9.64 | 9.33 |
| CWIP | 0.09 | 0.06 | 10.95 | 0 | 0.06 | 0.13 | 0.02 | 0 | 0 | 0 | 0 | 0 |
| Investments | 45.81 | 35.55 | 27.87 | 25.5 | 16.36 | 10.07 | 9.43 | 4.03 | 3.95 | 4.69 | 6.3 | 5.15 |
| Other Assets | 17.73 | 13.04 | 17.69 | 11.86 | 10.38 | 8.94 | 7.11 | 8.29 | 8.26 | 8.42 | 6.89 | 14.06 |
| Total Assets | 65.83 | 50.8 | 64.66 | 63.27 | 49.27 | 39.33 | 34.28 | 27.68 | 25.33 | 23.86 | 22.83 | 28.54 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 60.91 | -7.36 | -5.38 | -11.74 | -7.09 | -0.12 | -0.21 | 7.03 | 1.98 | 2.5 | 1.86 | 0.22 |
| Investing | -12.13 | 13.39 | -5.55 | 0.81 | 10.05 | 5.89 | 1.99 | -2.05 | 0.53 | 0.12 | -1.05 | 1.55 |
| Financing | -42.19 | -12.17 | 12.74 | 7.37 | -2.82 | -7.32 | -1.41 | -5.5 | -2.3 | -2.09 | -1.15 | 4.12 |
| Net Cash Flow | 6.59 | -6.13 | 1.8 | -3.57 | 0.14 | -1.55 | 0.37 | -0.52 | 0.2 | 0.53 | -0.34 | 5.89 |
| Free Cash Flow | 47.54 | 3.91 | -21.44 | -15.13 | -6.93 | -1.46 | 1.79 | 8.12 | 1.85 | 2.12 | 1.91 | -0.19 |
| CFO/OP | 5,865 | 102 | 13 | 60 | 97 | 0 | 3 | 1,717 | 185 | 183 | -185 | -16 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 3.72 | — | 1.27 | 59.62 | 22.08 | 39.3 | 73.49 | 44.06 | 55.39 | 45.88 | 56.62 | 32.64 |
| Inventory Days | 2.68 | — | 314 | 101 | 52.17 | 83.88 | 143 | 179 | 318 | 206 | 123 | 40.32 |
| Days Payable | 1.17 | — | 78.54 | 39.95 | 12.44 | 79.35 | 298 | 214 | 527 | 480 | 427 | 136 |
| Cash Conversion Cycle | 5.24 | — | 237 | 121 | 61.81 | 43.84 | -81.29 | 9.77 | -154 | -228 | -247 | -63.24 |
| Working Capital Days | -7.01 | — | -706 | -228 | -186 | -311 | -400 | -429 | -600 | -609 | -1,009 | -221 |
| ROCE % | -4.35% | -5.73% | -8.98% | -19.95% | -19.1% | -19.87% | -15.86% | -3.67% | -9.5% | 36.03% | -186.79% | -34.08% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Span Divergent insights
63 extracted metrics + investor summaries across FY11–FY26.
Documents
1
Span Divergent Limited - Intimation For Receipt Of Listing Approval
6 May - BSE approved listing of 18,01,481 preferential shares at Rs.32.16, allotted on 28 March 2026. 6 May - BSE approved listing of 18,01,481 preferential shares at Rs.32.16, allotted on 28 March 2026.
2
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
17 Apr - FY2025-26 annual large corporate disclosure filed; Span Divergent is not a large corporate. 17 Apr - FY2025-26 annual large corporate disclosure filed; Span Divergent is not a large corporate.
3
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
17 Apr - Company disclosed ₹1.92 crore borrowing and confirmed it is not a large corporate. 17 Apr - Company disclosed ₹1.92 crore borrowing and confirmed it is not a large corporate.
4
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Apr - RTA certificate confirms Regulation 74(5) compliance for quarter ended March 31, 2026. 9 Apr - RTA certificate confirms Regulation 74(5) compliance for quarter ended March 31, 2026.
Frequently Asked Questions about Span Divergent
What does Span Divergent Ltd do?
Incorporated in 1972, Span Divergent Ltd deals in different businesses through various subsidiaries.[1]
Where is Span Divergent Ltd (524727) listed?
Span Divergent Ltd trades under code 524727 on the BSE.
Which sector does Span Divergent Ltd belong to?
Span Divergent Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Span Divergent Ltd?
Span Divergent Ltd has a market capitalisation of ₹21.3 Cr, which places it in the Small Cap band.
What is the PE ratio of Span Divergent Ltd?
Span Divergent Ltd trades at a PE ratio of -5.90, against a book value of ₹20.46 per share.
What is the 52-week high and low of Span Divergent Ltd?
Over the last 52 weeks Span Divergent Ltd has traded between ₹21.76 and ₹51.49.
What is the Return on Equity (ROE) of Span Divergent Ltd?
Span Divergent Ltd reported a return on equity of -29.99%. Its debt-to-equity ratio is 0.48.
Company Information
Incorporated in 1972, Span Divergent Ltd deals in different businesses through various subsidiaries.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524727.md for Span Divergent Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.